OUR FOCUS
Harnessing Transformative Trends
From advanced imaging systems to wearable devices and telemedicine platforms, Medical Technology’s boundaries are blurring with other subsectors to play a central role in improving patient outcomes and healthcare delivery.
Our Medical Technology team supports both emerging and established companies, serving as a valued partner through M&A, capital raising, and strategic transactions.
Recent transactions
$50 Million
Sole Agent
At-the-Market Facility
March 2025
$350 Million
Joint Bookrunner
Rule 144A Convertible Senior Notes Offering
March 2025
$204 Million
Joint Bookrunner
Initial Public Offering
January 2025
UNDISCLOSED
Exclusive Financial Advisor
Sale to Bausch + Lomb
December 2024
Featured Insights
Podcasts
July 2025
Head of Patient Engagement and Patient-Centered Innovation, Raven, RA Capital’s healthcare incubator, Gunnar Esiason, MBA, MPH
Featured Research
July 2025
Biopharma / Chase a Check (Vol. 7) – Biopharma Cash Runway Map: 2023 – 2025
Articles
June 2025
